Editor’s note: Joan Sierfert Rose is CEO of LaunchBio.
DURHAM – The path to success for most early stage biotech companies is a shared one. This fall, our programs at LaunchBio highlight the benefits of partnerships between startups and larger companies, communicators, and experts.
LaunchBio’s Larger Than Life Science program in Durham Thursday, October 4, features a range of perspectives on how startups can build relationships and work with the business development teams at life science companies large and small.
We’re excited to welcome some companies as new presenters, including Jullian Jones, director of business development for Lilly Oncology, and Ann Kraft, executive director of IP Licensing and Strategic Transactions for Purdue Pharma. They will join Lisa Pfefferle, associate vice president of corporate development and licensing at LabCorp, and Gregg Davis, vice president of corporate and business development at Avadel Pharmaceuticals, in a panel moderated by Dan O’Korn, partner at Hutchison PLLC. Be sure to arrive early to get a seat for this presentation! You can register for the program here.
Also on the agenda for the October 4 program is a discussion with entrepreneurs and companies on how to make the most of hard-won capital dollars while growing a company, in a session we’re calling “The Big Stretch.”
Finally, there’s a chance to win bragging rights for the scientific team with the top lab skills.
Our colleagues at Eppendorf are posing a series of fun and educational competitive challenges in the “Pipetting Olympics,” which will culminate in the awarding of prizes for skill, speed and accuracy. It’s one competition when bench lab skills will be worth more than bench-pressing skills. You can learn more and sign up here.
